CASI Pharmaceuticals
CASI
CASI
69 hedge funds and large institutions have $72.3M invested in CASI Pharmaceuticals in 2021 Q2 according to their latest regulatory filings, with 17 funds opening new positions, 14 increasing their positions, 23 reducing their positions, and 34 closing their positions.
Holders
69
Holders Change
-17
Holders Change %
-19.77%
% of All Funds
1.2%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
17
Increased
14
Reduced
23
Closed
34
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
Renaissance Technologies
New York
|
$2.4M |
| 2 |
2
Millennium Management
New York
|
$1.72M |
| 3 |
E
3
Ergoteles
New York
|
$466K |
| 4 |
4
Marshall Wace
London,
United Kingdom
|
$347K |
| 5 |
TEE
5
Tibra Equities Europe
London,
United Kingdom
|
$335K |
Top Sellers
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
101
Northwestern Mutual Wealth Management
Milwaukee,
Wisconsin
| $0 | 132 | – | – |
|
|
CFGS
102
Concourse Financial Group Securities
Birmingham,
Alabama
| – | – | – | – |
|
|
JPLA
103
Joseph P. Lucia & Associates
Yorktown Heights,
New York
| $0 | 1 | – | – |
|
|
QCG
104
Quadrant Capital Group
Cincinnati,
Ohio
| $0 | 266 | +266 | New |
|